9WN-18038-11034
3 vaccinations
2 coded responses
32 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 228 / VA
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-27
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Registered in v-safe
-
2021-03-30
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Swelling · HeadacheAdult check-in
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-10
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2021-04-16
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Good · Site: Pain, SwellingFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-17
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-18
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tirednessAdult check-in
-
2021-04-19
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-20
- 2021-04-21
-
2021-04-23
Survey response — day 7, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Longer period than usualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-07
- 2021-05-16
- 2021-05-21
- 2021-05-30
- 2021-07-16
- 2021-10-15
-
2022-03-07
Dose 3 — Pfizer-BioNTech
-
2022-03-09
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Headache, Muscle or body aches · Be unable to work or attend schoolAdult check-in
-
2022-03-10
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Swelling · Nausea, VomitingAdult check-in
- 2022-03-11
- 2022-03-12
- 2022-03-15
- 2022-03-21
- 2022-03-28
- 2022-04-04
- 2022-04-13
- 2022-04-18
- 2022-06-06
- 2022-09-05
- 2023-03-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-27 | Pfizer-BioNTech | |
| 2 | 2021-04-16 | Pfizer-BioNTech | |
| 3 | 2022-03-07 | Pfizer-BioNTech | No |
Free text
Release 7 — day 0, dose 2
Systemic reaction (other): Lightheaded
Release 7 — day 7, dose 2
Systemic reaction (other): Longer period than usual
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
| SRO | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release